| |
| |
|
| Insider
Information: |
Pauwels Eric |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
97,694 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,231,732 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
97,694 |
|
|
| Total
Value |
$2,231,732 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
19
|
|
Stock
price went up :
|
0
|
9
|
| Stock
price went down : |
0
|
10
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -279.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Accuray Inc |
ARAY |
SVP Chief Marketing Of... |
2011-02-28 |
30,000 |
2011-02-28 |
0 |
Premium* |
|
|
NPS Pharmaceuticals Inc |
NPSP |
President, NPS Pharma ... |
2015-02-21 |
0 |
2011-09-26 |
0 |
Premium* |
|
|
PTC Therapeutics, Inc. |
PTCT |
|
2024-04-17 |
67,694 |
2020-04-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
49 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARAY |
Accuray Inc |
SVP Chief Marketing Officer |
• – – |
2011-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2011-09-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
SVP & Chief Commercial Officer |
• – – |
2013-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,866 |
24,600 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
SVP & Chief Commercial Officer |
• – – |
2013-02-07 |
4 |
D |
$8.61 |
$16,609 |
D/D |
(1,929) |
22,671 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
SVP & Chief Commercial Officer |
• – – |
2014-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,867 |
25,391 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
SVP & Chief Commercial Officer |
• – – |
2014-02-07 |
4 |
D |
$35.13 |
$61,794 |
D/D |
(1,759) |
23,632 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
SVP & Chief Commercial Officer |
• – – |
2014-02-13 |
4 |
D |
$38.30 |
$108,312 |
D/D |
(2,828) |
28,904 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
SVP & Chief Commercial Officer |
• – – |
2014-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,100 |
31,732 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
• – – |
2014-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,667 |
30,571 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
• – – |
2014-08-01 |
4 |
D |
$27.86 |
$17,273 |
D/D |
(620) |
29,951 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
• – – |
2014-09-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
29,951 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
• – – |
2014-09-26 |
4 |
D |
$27.55 |
$142,847 |
D/D |
(5,185) |
24,766 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
• – – |
2015-02-07 |
4 |
D |
$45.85 |
$76,203 |
D/D |
(1,662) |
23,104 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
• – – |
2015-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,867 |
24,766 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
• – – |
2015-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,787 |
25,891 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
• – – |
2015-02-12 |
4 |
D |
$45.85 |
$43,878 |
D/D |
(957) |
24,934 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
• – – |
2015-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,100 |
33,034 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
• – – |
2015-02-13 |
4 |
D |
$45.88 |
$137,869 |
D/D |
(3,005) |
30,029 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
• – – |
2015-02-21 |
4 |
D |
$46.00 |
$1,381,334 |
D/D |
(30,029) |
0 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
• – – |
2020-04-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
33,841 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
• – – |
2020-11-03 |
4 |
AS |
$56.50 |
$349,961 |
D/D |
(6,194) |
27,647 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-01-05 |
4 |
S |
$62.37 |
$66,549 |
D/D |
(1,067) |
27,080 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,200 |
37,280 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-01-25 |
4 |
S |
$62.05 |
$26,745 |
D/D |
(431) |
36,849 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-02-01 |
4 |
S |
$56.96 |
$20,618 |
D/D |
(362) |
36,487 |
0 |
% |
|
49 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
